Infusion: Check With Your Carrier About Tysabri Coding

Why This Topic Matters

Tysabri was a new therapy at the time, and payment practices were still evolving. Understanding the article helps coders and billing teams recognize that coverage and claim submission approaches may differ by payer, setting, and carrier policy.

Article Sections

1. Coding and payment context for Tysabri

   Introduces the medication, its use in multiple sclerosis, and the general challenge of establishing billing approaches during early adoption. It frames the article around infusion, drug reporting, and payer uncertainty.

2. Medicare guidance for administration coding

   Summarizes broad Medicare-related guidance on reporting infusion administration and references the administrative guidance cited in the article. It focuses on how the article situates this therapy within existing administration code categories.

3. Carrier policy and drug code considerations

   Covers the article's discussion of payer-specific drug coding approaches in different settings and the need to verify local coverage policy. It also notes the role of carrier guidance and claim form reporting practices.

4. Provider billing practices and reimbursement concerns

   Describes how some practices handled acquisition and billing during the early period and the operational concerns tied to stocking and reimbursement. It addresses general office workflow and payment uncertainty.